J. Martínez-Cadilla

Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment.

X. Calvet, M. Chaparro, J. Mendoza, 2016, Journal of Crohn's & colitis.

Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of Epi-IBD 2011 study in the Vigo area.

D. Martínez-Ares, C. González-Portela, V. Hernández, 2021, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study

C. O'Morain, V. Andersen, L. Kupčinskas, 2018, European journal of gastroenterology & hepatology.

Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort—An ECCO-EpiCom Study

C. O'Morain, V. Andersen, L. Kupčinskas, 2017, Journal of Crohn's & colitis.

Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study.

D. Martínez-Ares, C. González-Portela, V. Hernández, 2015, Gastroenterologia y hepatologia.

Increased risk of thiopurine‐related adverse events in elderly patients with IBD

J. Gisbert, X. Calvet, M. Mínguez, 2019, Alimentary pharmacology & therapeutics.

Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu

J. Gisbert, I. Bastón-Rey, M. Chaparro, 2021, Journal of clinical medicine.

Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry.

J. Gisbert, M. Piqueras, A. Lucendo, 2020, Journal of Crohn's & colitis.

Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index.

V. Hernández, S. Pereira, V. del Campo, 2017, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

OP034 The initiation of thiopurines in elderly patients with inflammatory bowel disease is associated with an increased risk of adverse effects: a case–control study of the ENEIDA registry

J. Gisbert, X. Calvet, J. Panés, 2018 .